BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23018355)

  • 1. Soluble trail as a marker of efficacy of allergen-specific immunotherapy in patients with allergic rhinoconjunctivitis.
    Yalcin AD; Gumuslu S; Parlak GE; Bısgın A
    Med Sci Monit; 2012 Oct; 18(10):CR617-21. PubMed ID: 23018355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cc-chemokine eotaxin as a marker of efficacy of specific immunotherapy in patients with intermittent IgE-mediated allergic rhinoconjunctivitis.
    Jahnz-Rózyk K; Targowski T; Głodzinska-Wyszogrodzka E; Płusa T
    Allergy; 2003 Jul; 58(7):595-601. PubMed ID: 12823117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial.
    Hylander T; Larsson O; Petersson-Westin U; Eriksson M; Kumlien Georén S; Winqvist O; Cardell LO
    Respir Res; 2016 Jan; 17():10. PubMed ID: 26817454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seasonal Local Allergic Rhinitis in Areas With High Concentrations of Grass Pollen.
    Blanca-Lopez N; Campo P; Salas M; García Rodríguez C; Palomares F; Blanca M; Canto G; Feo Brito F; Rondon C
    J Investig Allergol Clin Immunol; 2016; 26(2):83-91. PubMed ID: 27164623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization.
    Vourdas D; Syrigou E; Potamianou P; Carat F; Batard T; André C; Papageorgiou PS
    Allergy; 1998 Jul; 53(7):662-72. PubMed ID: 9700035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of short-term immunotherapy using molecular standardized grass and rye allergens compared with symptomatic drug treatment on rhinoconjunctivitis symptoms, skin sensitivity, and specific nasal reactivity.
    Klimek L; Mewes T; Wolf H; Hansen I; Schnitker J; Mann WJ
    Otolaryngol Head Neck Surg; 2005 Oct; 133(4):538-43. PubMed ID: 16213926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis.
    La Rosa M; Ranno C; André C; Carat F; Tosca MA; Canonica GW
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 1):425-32. PubMed ID: 10452766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 300IR 5-Grass pollen sublingual tablet offers relief from nasal symptoms in patients with allergic rhinitis.
    Serrano E; Wahn HU; Didier A; Bachert C
    Am J Rhinol Allergy; 2014; 28(6):471-6. PubMed ID: 25335122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. @IT2020: An innovative algorithm for allergen immunotherapy prescription in seasonal allergic rhinitis.
    Arasi S; Castelli S; Di Fraia M; Villalta D; Tripodi S; Perna S; Dramburg S; Brighetti MA; Conte M; Martelli P; Sfika I; Travaglini A; Verardo PL; Villella V; Matricardi PM
    Clin Exp Allergy; 2021 Jun; 51(6):821-828. PubMed ID: 33759270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. II. Side-effects.
    Winther L; Malling HJ; Mosbech H
    Allergy; 2000 Sep; 55(9):827-35. PubMed ID: 11003446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intradermal grass pollen immunotherapy increases T
    Slovick A; Douiri A; Muir R; Guerra A; Tsioulos K; Hay E; Lam EPS; Kelly J; Peacock JL; Ying S; Shamji MH; Cousins DJ; Durham SR; Till SJ
    J Allergy Clin Immunol; 2017 Jun; 139(6):1830-1839.e13. PubMed ID: 27773851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous versus sublingual immunotherapy.
    Lin CH; Alandijani S; Lockey RF
    Expert Rev Clin Immunol; 2016 Aug; 12(8):801-3. PubMed ID: 27253418
    [No Abstract]   [Full Text] [Related]  

  • 15. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with grass allergen peptides improves symptoms of grass pollen-induced allergic rhinoconjunctivitis.
    Ellis AK; Frankish CW; O'Hehir RE; Armstrong K; Steacy L; Larché M; Hafner RP
    J Allergy Clin Immunol; 2017 Aug; 140(2):486-496. PubMed ID: 28236469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen.
    Patel P; Holdich T; Fischer von Weikersthal-Drachenberg KJ; Huber B
    J Allergy Clin Immunol; 2014 Jan; 133(1):121-9.e1-2. PubMed ID: 23870670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: a systematic review.
    Röder E; Berger MY; de Groot H; van Wijk RG
    Pediatr Allergy Immunol; 2008 May; 19(3):197-207. PubMed ID: 18221463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic mechanisms of a short-course of Lolium perenne peptide immunotherapy: A randomized, double-blind, placebo-controlled trial.
    Sharif H; Singh I; Kouser L; Mösges R; Bonny MA; Karamani A; Parkin RV; Bovy N; Kishore U; Robb A; Katotomichelakis M; Holtappels G; Derycke L; Corazza F; von Frenckell R; Wathelet N; Duchateau J; Legon T; Pirotton S; Durham SR; Bachert C; Shamji MH
    J Allergy Clin Immunol; 2019 Sep; 144(3):738-749. PubMed ID: 30844425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with allergic rhinoconjunctivitis.
    Turgay M; Keskin G; Kminkli G; Sentürk T; Tutkak H; Duman M; Tokgöz G
    Allergol Immunopathol (Madr); 1996; 24(3):129-31. PubMed ID: 8766745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.